Efficacy and safety of luseogliflozin as monotherapy in Japanese patients with type 2 diabetes mellitus: a randomized, double-blind, placebo-controlled, phase 3 study - Concepedia

Concepedia

Publication | Open Access

Efficacy and safety of luseogliflozin as monotherapy in Japanese patients with type 2 diabetes mellitus: a randomized, double-blind, placebo-controlled, phase 3 study

DOI Full Paper Access

145

Citations

14

References

2014

Year

Yutaka Seino, Takashi Sasaki, Atsushi Fukatsu, Michito Ubukata, Soichi Sakai, Yoshishige Samukawa

Current Medical Research and Opinion

Abstract

JapicCTI-111661.

References

	Year	Citations

Page 1